Medacist Introduces RxDiversion Scorecard

Medacist's unique combination of in-depth healthcare industry knowledge, new technology solutions, best-in-class customer service, and attention to detail has established it as the premier resource in drug diversion analytics.

FREMONT, CA: Medacist, the industry leader in drug diversion technology solutions, launched the Medacist RxDiversion Scorecard, a new online set of guidelines to help hospitals and healthcare institutions understand their specific needs and evaluate drug diversion analytical solutions.

Backed by over two decades of drug diversion experience and data analytics, the new scorecard system outlines critical factors in assessing a healthcare facility's aptitude in drug diversion initiatives along with potential risk factors otherwise unknown. As Medacist continues its sole business objective in providing best-in-class drug diversion analytics, this latest announcement reaffirms its commitment to providing better solutions and more actionable insights to better protect patient outcomes.

As the landscape around drug diversion instances continues to evolve and becomes increasingly complex, strict criteria were developed for evaluating drug diversion solutions in organizations.